We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+26.22%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$246B
AUM Growth
+$40.4B
Cap. Flow
-$3.46B
Cap. Flow %
-1.41%
Top 10 Hldgs %
22.52%
Holding
3,466
New
266
Increased
1,402
Reduced
1,481
Closed
200

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$613M
2
MTCH icon
Match Group
MTCH
+$518M
3
META icon
Meta Platforms (Facebook)
META
+$508M
4
RTX icon
RTX Corp
RTX
+$456M
5
LLY icon
Eli Lilly
LLY
+$364M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$828M
2
MSFT icon
Microsoft
MSFT
+$510M
3
GILD icon
Gilead Sciences
GILD
+$465M
4
MRK icon
Merck
MRK
+$376M
5
WMT icon
Walmart Inc
WMT
+$369M

Sector Composition

Rank Sector Weight
1 Technology 23.64%
2 Healthcare 14.1%
3 Financials 12.4%
4 Consumer Discretionary 12.19%
5 Communication Services 9.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMTD
851
DELISTED
TD Ameritrade Holding Corp
AMTD
$27.3M 0.01%
749,244
-15,653
-2% -$589K
VONV icon
852
Vanguard Russell 1000 Value ETF
VONV
$21.2B
$27.2M 0.01%
+550,000
New +$26.6M
BRSL
853
Brightstar Lottery PLC
BRSL
$2.03B
$27.1M 0.01%
3,050,186
+568,049
+23% +$4.43M
RPD icon
854
Rapid7
RPD
$773M
$27.1M 0.01%
532,040
+62,008
+13% +$2.89M
HTLF
855
DELISTED
Heartland Financial USA, Inc.
HTLF
$27.1M 0.01%
811,374
-31,180
-4% -$975K
SMTC icon
856
Semtech
SMTC
$13B
$27.1M 0.01%
519,433
-88,193
-15% -$4.13M
TXG icon
857
10x Genomics
TXG
$6.61B
$27.1M 0.01%
+320,156
New +$24.9M
HUN icon
858
Huntsman Corp
HUN
$1.77B
$27.1M 0.01%
1,506,764
-600,867
-29% -$10.1M
SANM icon
859
Sanmina
SANM
$10.9B
$27M 0.01%
1,078,983
-49,723
-4% -$1.31M
KMPR icon
860
Kemper
KMPR
$1.68B
$26.9M 0.01%
370,634
-24,844
-6% -$1.66M
ATRC icon
861
AtriCure
ATRC
$2.11B
$26.8M 0.01%
596,116
-43,094
-7% -$1.88M
ENV
862
DELISTED
ENVESTNET, INC.
ENV
$26.8M 0.01%
364,321
+11,276
+3% +$737K
ATKR icon
863
Atkore
ATKR
$3.16B
$26.7M 0.01%
976,210
-194,644
-17% -$4.82M
MASI
864
DELISTED
Masimo
MASI
$26.7M 0.01%
116,946
+8,035
+7% +$1.76M
TEVA icon
865
Teva Pharmaceuticals
TEVA
$41.2B
$26.6M 0.01%
2,159,937
+795,681
+58% +$9M
LITE icon
866
Lumentum
LITE
$69.3B
$26.6M 0.01%
326,965
-228,999
-41% -$17.4M
BOX icon
867
Box
BOX
$4.6B
$26.6M 0.01%
1,281,425
+679,377
+113% +$11.9M
HPP
868
Hudson Pacific Properties
HPP
$779M
$26.5M 0.01%
150,602
-287,809
-66% -$49M
UPBD icon
869
Upbound Group
UPBD
$1.16B
$26.5M 0.01%
950,883
-20,226
-2% -$449K
FSS icon
870
Federal Signal
FSS
$7.83B
$26.5M 0.01%
889,699
-15,885
-2% -$450K
VER
871
DELISTED
VEREIT, Inc.
VER
$26.3M 0.01%
819,611
-2,154,445
-72% -$60M
MMYT icon
872
MakeMyTrip
MMYT
$5.64B
$26.3M 0.01%
1,718,652
+732,200
+74% +$10.9M
KNX icon
873
Knight Transportation
KNX
$11.4B
$26.3M 0.01%
631,224
+40,043
+7% +$1.53M
FAF icon
874
First American
FAF
$7.58B
$26.3M 0.01%
547,715
-276,410
-34% -$13.1M
RRX icon
875
Regal Rexnord
RRX
$11.9B
$26.3M 0.01%
300,695
-70,573
-19% -$5.29M

Similar funds

Nuveen's Q2 2020 Portfolio in Review

As of Q2 2020, Nuveen held 3,466 positions worth $246B, up 20% from $205B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Nuveen's Q2 2020 filing shows 266 new, 1,402 increased, 1,481 reduced and 200 closed positions. Its largest new stake was Zoom: 841,153 shares worth $213M. The largest sale was Amazon, an estimated $828M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • Nuveen's largest Q2 2020 buy was Zoom: 841,153 shares worth $213M.
  • Nuveen added most to AbbVie in Q2 2020, an estimated $613M increase.
  • Nuveen's biggest Q2 2020 reduction was Amazon, cutting an estimated $828M.
  • Nuveen fully exited Allergan plc in Q2 2020, selling an estimated $212M.
  • Nuveen's ten largest holdings make up 23% of its $246B portfolio in Q2 2020.
  • Nuveen opened 266 new positions and closed 200 in Q2 2020.
  • Nuveen's portfolio value rose 20% quarter-over-quarter to $246B.

Based on Nuveen's 13F filing for Q2 2020, filed 14 Aug 2020.